ALPHA
#Oncology #OBGYN

Ovarian Cancer

evan Jan. 21, 2024

Often presents late due to the non-specific symptoms resulting in a worse prognosis. Presents with abdominal bloating, early satiety, pelvic pain, pelvic mass, weight loss, ascites criteria for 2 week referral.

  • Surface epithelial tumours - serous, mucinous, endometrioid
  • Germ cell tumours - arise from oocyte, teratomas most common
    • dysgerminoma - malignant, very rare LDH tumour marker
    • yolk sac tumour - malignant, α-FP
    • Choriocarcinoma - extremely malignant, β-HCG
  • Sex-cord stroma - rare, produce steroid hormones

CA125 can be used as a tumour marker but not very specific

FIGO staging - 

  • Stage 1: Confined to the ovary
  • Stage 2: Spread past the ovary but inside the pelvis
  • Stage 3: Spread past the pelvis but inside the abdomen
  • Stage 4: Spread outside the abdomen (distant metastasis)

Protective factors

  • Combined oral contraceptive 
  • Breastfeeding
  • Pregnancy

Comments